May 23, 2017 — IBA announced that the first patient has been treated with pencil beam scanning (PBS) technology at the Institut Curie in Orsay, France.
Since its opening in 1991, more than 8,000 patients have been treated at the Institute Curie Proton Therapy Center. During this time, the center has gradually upgraded its equipment to increase the number of indications that can be treated. Today, around fifty patients are treated every day in the three rooms available. The rooms include one gantry, one fixed beam and an eye line.
PBS is the latest addition to the IBA Proteus Plus solution in operation in Orsay. PBS enables the clinician to deliver intensity modulated proton therapy by accurately targeting the tumor with controlled dose intensity and precise spatial distribution. To date, more than 200,000 fractions have been delivered with IBA pencil beam scanning equipment.
Remi Dendale, M.D., deputy director of the Institute Curie Proton Therapy Center, commented, “We are very happy to upgrade our equipment with the latest technology available. This enables us to offer proton therapy to more patients by broadening the list of indications we can treat. Thanks to the excellent collaboration with IBA, our team has been able to implement this new feature with zero impact on our clinical operations.”
For more information: www.iba-worldwide.com
March 28, 2024 
